Palisade Bio
PALI
10 hedge funds and large institutions have $1.43M invested in Palisade Bio in 2021 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
196% more capital invested
Capital invested by funds: $485K → $1.43M (+$949K)
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
11% more funds holding
Funds holding: 9 → 10 (+1)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$493K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$182K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$40.5K |
| 4 |
VF
Virtu Financial
New York
|
+$20.3K |
| 5 |
EWM
Evermay Wealth Management
Arlington,
Virginia
|
+$13.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$147K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$60.8K |
| 3 |
Bank of New York Mellon
New York
|
-$6.75K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $623K | +$493K | +73 | +913% |
|
|
VF
2
Virtu Financial
New York
| $226K | +$20.3K | +3 | +11% |
|
|
3
Geode Capital Management
Boston,
Massachusetts
| $202K | +$182K | +27 | New |
|
4
HighTower Advisors
Chicago,
Illinois
| $170K | – | – | – |
|
|
5
Bank of New York Mellon
New York
| $75K | -$6.75K | -1 | -9% |
|
|
6
Citadel Advisors
Miami,
Florida
| $48K | +$40.5K | +6 | New |
|
7
Northern Trust
Chicago,
Illinois
| $31K | – | – | – |
|
8
UBS Group
Zurich,
Switzerland
| $27K | +$13.5K | +2 | +100% |
|
|
EWM
9
Evermay Wealth Management
Arlington,
Virginia
| $17K | +$13.5K | +2 | New |
|
10
BlackRock
New York
| $6K | – | – | – |
|
11
Bank of America
Charlotte,
North Carolina
| $4K | – | – | – |
|
12
Morgan Stanley
New York
| $3K | – | – | – |
|
|
TRCT
13
Tower Research Capital (TRC)
New York
| $1K | -$60.8K | -9 | Closed |
|
14
Osaic Holdings
Scottsdale,
Arizona
| $1K | – | – | – |
|
|
15
Renaissance Technologies
New York
| – | -$147K | -37 | Closed |
|
PALI Hedge Fund Activity: Q1 2021 in Review
10 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q1 2021, worth a combined $1.43M — up 196% from $485K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new PALI positions and 2 closed out — a net gain of 1 holder — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Vanguard Group, adding an estimated $493K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $147K sold.
- 10 institutional investors held Palisade Bio (PALI) as of Q1 2021, up from 9 in Q4 2020.
- Funds reported $1.43M of Palisade Bio stock for Q1 2021, up 196% quarter-over-quarter.
- 3 funds opened new Palisade Bio positions in Q1 2021 and 2 closed out, a net change of +1 holder.
- The largest Palisade Bio buyer in Q1 2021 was Vanguard Group, an estimated $493K added.
- The largest Palisade Bio seller in Q1 2021 was Renaissance Technologies, an estimated $147K sold.
Based on aggregated 13F filings for Q1 2021.